# Layer B — Current-developments Substrate

## Purpose

Time-of-evaluation snapshot of force-topology current state.
Refreshed per-run-start (NOT quarterly).

Captures four watchpoints surfaced during Layer D synthesis:
1. AI-orchestration-becoming-table-stakes timeline
2. Regulatory-substrate-closure progression for compounded-GLP-1
3. x402 + agent-transaction substrate emergence
4. Manufacturer-DTC capture trajectory

Plus emerging-exemplars section + cross-references to Layer A
architectures whose force-topology is materially affected by current
developments.

## Refresh discipline

- Refresh trigger: per-run-start (each AlphaMo run reloads current Layer B)
- Refresh process: web research pass on each section's watchpoints +
  rewrite affected entries + verify cross-references to Layer A still
  hold
- Snapshot date: Wednesday May 20, 2026 (this version)
- Stale-by-default: any section dated >90 days old should be flagged
  and re-researched before use

## Schema (extends Layer D)

```yaml
schema:
  inherits: layer-d-evidence-tags (E/I/C/U) + compressed-yaml-format

  section-fields:
    - id
    - routing-target    # NEW: proposer / stage-3 / both
    - snapshot-date     # NEW: date of last verification
    - watchpoint-ref    # cross-ref to layer-d insight or anti-pattern
    - current-state     # compressed-yaml; bracket-prefix tagged
    - signals           # what to watch in next refresh cycle
    - cross-ref         # affected layer-a architectures + layer-d entries

  routing-targets:
    proposer: candidate-architecture-generation context; force-topology + emerging-exemplars + AI-capability-landscape go here
    stage-3: candidate-evaluation context; regulatory-state + substrate-window-status + market-conditions go here
    both: shared substrate context (force-topology shifts affecting both reasoning + evaluation)
```

---

## Section 1 — AI capability landscape

```yaml
- id: layer-b-ai-capability-landscape
  routing-target: proposer (primary) + stage-3 (table-stakes-timing assessment)
  snapshot-date: 2026-05-20
  watchpoint-ref: insight-6-fails-when-AI-orchestration-becomes-table-stakes / pattern-6-NEW-MECHANISM-AI-orchestration-discipline

  current-state:
    frontier-models-may-2026:
      - [E] claude-opus-4-7 (anthropic; current production frontier; 64.3% SWE-Bench-Verified; 80.9% SWE-bench via Claude Code agent-loop; managed-agents-beta + agent-SDK)
      - [E] gpt-5-5 (openai; released April 23 2026 codename "Spud"; 82.7% Terminal-Bench-2.0 / 58.6% SWE-Bench-Pro / 78.7% OSWorld-Verified; native computer-use built into model)
      - [E] gpt-5-5-pro (openai; parallel test-time compute variant; higher accuracy cognitive tasks)
      - [E] gemini-3 + project-mariner (google; 83.5% WebVoyager browser-navigation benchmark; folded into Gemini API)
      - [E] deepseek-v4 + qwen-3-6 + kimi-k2-6 + glm-5 (chinese-frontier open-weight; multi-vendor capability dispersion)

    agent-frameworks:
      - [E] anthropic Managed Agents (beta) + Agent SDK (real agent-loop + tool-use + file-editing + shell-execution)
      - [E] openai Codex CLI (open-source terminal agent)
      - [E] google A2A protocol (Linux Foundation governance; 150+ partners; cross-framework agent collaboration)
      - [E] microsoft Agent Framework (autogen + semantic kernel merged into unified enterprise platform)
      - [E] aws Kiro (10 simultaneous development tasks autonomously)
      - [E] devin-3-0 (dynamic re-planning + self-healing code + legacy-codebase migration)
      - [E] MCP (Model Context Protocol; donated to Linux Foundation; universal agent-tool-interoperability standard)

    capability-benchmarks-state:
      - [E] METR HCAST (Human-Calibrated Autonomy Software Tasks): measures longest-task-length-in-human-minutes at 50% success rate; structural rather than score-based
      - [I] 2-year capability-expansion: agent-task-completion at 14% (2024) → 60%+ (2026); most dramatic expansion in any agent benchmark
      - [E] scaffolding-matters: same model can score 30 points apart on GAIA depending on agent-loop quality + retrieval + tool-definitions
      - [I] "home-field advantage" in benchmarks: models peak when paired with their native frameworks (anthropic Claude with Agent SDK / openai GPT-5.5 with Codex CLI / etc.)

    economics:
      - [E] solopreneur-tech-stack: $3,000-$12,000/year all-in (95-98% cost reduction vs traditional staffing equivalent)
      - [I] operating-margins for AI-first-solo-businesses: 60-80% (vs 10-30% traditional)
      - [E] 38% of seven-figure businesses solopreneur-led (early 2026 / scalable.news)
      - [E] solo-founded startups = 36.3% of new ventures (early 2026)
      - [E] sequoia-capital adjusting underwriting models for "agentic leverage" (small teams produce outsized output via AI-orchestration)

  becoming-table-stakes-assessment:
    [I] AI-orchestration-as-architectural-foundation is BECOMING table-stakes but NOT YET arrived
    evidence-for-becoming: multi-vendor frontier-capability convergence + standardized frameworks + MCP + agent-SDK availability + solopreneur-stack commoditized at $3-12K
    evidence-against-arrived: context-engineering remains specialized discipline + scaffolding-variance produces 30-point benchmark spreads + execution-asymmetry from operator-discipline-+-AI-orchestration combinations still produces medvi-type outcomes
    [I] window-status: open but compressing; insight-6 mechanism still viable; horizon ~12-24 months for full table-stakes-arrival
    [E] amodei-bet-may-2025: first billion-dollar one-person company by 2026; 70-80% odds; "seven months left on the bet" as of May 2026 per anthropic public statement

  signals:
    - watch: GPT-5.5 / Claude-Opus-4.7 / Gemini-3 capability-gap convergence pace (if all three reach equivalent agentic-task performance, scaffolding-asymmetry shrinks)
    - watch: agent-SDK adoption-rate vs custom-orchestration; if SDK-built-agents reach parity with custom-context-engineered-agents, asymmetry closes
    - watch: HCAST + GAIA + Terminal-Bench score-progression on long-horizon tasks (>4hr human-equivalent)
    - watch: cost-per-effective-task trajectory (token-cost × tokens-per-task × reliability)

  cross-ref:
    affects-layer-a:
      - medvi.md (F3 AI-capability-shift emergence-force; current state durable; assessing becoming-table-stakes timeline)
    affects-layer-d:
      - insight-6-thin-operator-ai-orchestration-rented-infrastructure (works-when-condition-2 + fails-when-condition-2 evaluated against this section)
      - pattern-6-NEW-MECHANISM-AI-orchestration-discipline (current-state of mechanism's substrate)
    sprint-12-routing: proposer (force-topology + capability-landscape context) > stage-3 (table-stakes-timing for evaluator scrutiny)
```

---

## Section 2 — Regulatory transitions affecting solo-billion architectures

```yaml
- id: layer-b-regulatory-transitions
  routing-target: stage-3 (primary) + proposer (substrate-window-evaluation)
  snapshot-date: 2026-05-20
  watchpoint-ref: insight-6-fails-when-regulatory-substrate-closure / sub-pattern-b-mechanism-variant-3-regulatory-substrate-closure

  compounded-glp-1-substrate-closure:
    timeline:
      - [E] 2022-2024: semaglutide + tirzepatide on FDA drug-shortage-list → 503A + 503B compounding pathways legal at scale
      - [E] 2024-10: tirzepatide removed from shortage-list (1st door closes)
      - [E] 2025-02: semaglutide removed from shortage-list (2nd door closes; liraglutide still on)
      - [E] 2025: 50+ FDA warning letters to compounders + telehealth platforms
      - [E] 2025-04-22 / 2025-05-22: enforcement-discretion periods ended
      - [E] 2026-02: FDA press release "FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs"
      - [E] 2026-02-20: FDA warning letter #721455 to Medvi
      - [E] 2026-03: industry-wide 30+ FDA warning letters
      - [E] 2026-03: hims-hers exits compounded-GLP-1 advertising; pivots to novo-nordisk-branded-partnership
      - [E] 2026-04-30: FDA proposes excluding semaglutide + tirzepatide + liraglutide from 503B Bulks List (91 Fed. Reg. 23431)
      - [E] 2026-05-01: Federal Register notice published; docket 2026-08552
      - [E] 2026-06-30: comment period closes
      - [I] 2026-Q3-or-Q4 OR 2027-Q1: final determination expected (FDA pattern: proposed-rule-to-final ~6-12 months)
      - [I] post-finalization: 503B-compounding-pathway closed for major GLP-1s; underlying technology unchanged but legal-pathway-to-operate-at-scale removed

    structural-determination:
      - [E] FDA-stated-rationale: "no clinical need for outsourcing facilities to compound" when FDA-approved drugs available
      - [E] FDA explicitly rejects affordability + insurance-access as constituting clinical need
      - [E] 503A patient-specific compounding remains legal (case-by-case patient-needs basis) but cannot replicate 503B industrial-scale
      - [E] liraglutide still on shortage-list → compoundable under shortage-exception until shortage resolves
      - [E] DOJ enforcement active; Novo + Lilly civil litigation ongoing

    market-impact:
      - [E] compounded-GLP-1s reached ~30% of US-supply at 2024 peak
      - [E] hims-hers sub-pattern-D-adjacent transition: branded-novo-partnership operationalized 2025-2026; margin compression from compounded ~16% to branded ~5.5%
      - [E] medvi vertical-diversification race: men's-health Feb 2026 + meal-delivery Mar 2026 + planned women's-health + hormone-therapy + hair-loss + skincare (Sub-pattern-D candidate execution)
      - [I] other compounded-GLP-1 platforms (Ro + LifeMD + Henry Meds + Trimi + dozens-smaller) face same substrate-closure; mass extinction-event for category-template likely 2026-2027

  other-regulatory-windows:
    [I] solo-billion regulatory-arbitrage windows currently active or watched:
    - crypto + stablecoin rails: regulatory-clarification 2025-2026; SEC + CFTC stance softening; x402 + agentic-payments substrate emergence (see Section 3)
    - cannabis state-legal-federal-illegal: federal-rescheduling discussion ongoing; window remains open at state level; uncertain federal trajectory
    - online-gambling: jurisdiction-by-jurisdiction regulatory-closure pattern; window-narrowing over decade-scale
    - cross-border-DTC-pharmacy (mexico + canada + india + uk): persistent arbitrage; regulatory-tolerance variable by country-pair
    - peptides + research-chemicals (BPC-157 + thymosin + tirzepatide-research-chemicals): gray-zone; selectorate enforcement only

  fed-rescue-precedent + TBTF policy:
    [E] 2008 AIG-rescue-precedent ($182B Fed commitment; ~$22.7B profit) remains active policy-template
    [I] post-2008 SIFI designation framework: AIG SIFI 2013-2017 then removed; current SIFI list active
    [I] post-2022 banking crises (SVB + Signature + First Republic 2023; regional-bank-stress 2024-2025): Fed + FDIC interventions reproduce 2008 patterns
    [E] proposer-implication: architectures-dependent-on-Fed-intervention-for-survival treat exogenous-variable as architectural-asset = load-bearing-error per anti-pattern-3 (systemic-leverage-failure)

  signals:
    - watch: 2026-06-30 503B Bulks List comment period close + subsequent FDA final determination
    - watch: liraglutide shortage-list status (remaining compoundable substrate)
    - watch: hims-hers + medvi vertical-diversification execution Q3-Q4 2026 (Sub-pattern-D-vs-Sub-pattern-B trajectory resolution)
    - watch: DOJ enforcement escalation against thin-operator-telehealth specifically
    - watch: 503A enforcement-tightening (currently legal-but-low-scale; potential next regulatory-tightening target)

  cross-ref:
    affects-layer-a:
      - medvi.md (F1 regulatory-window-closing + closing-conditions actively triggering)
      - hims-hers (Sub-pattern-D-adjacent in-progress)
    affects-layer-d:
      - insight-6-fails-when-regulatory-substrate-closure (active firing)
      - sub-pattern-b-mechanism-variant-3-regulatory-substrate-closure (active instance: medvi branch-b trajectory)
      - anti-pattern-1-fraud-as-architecture (regulatory-enforcement-cascade follows same pattern as fraud-exposure)
    sprint-12-routing: stage-3 (regulatory-state for candidate-evaluation) > proposer (substrate-window-status for candidate-generation)
```

---

## Section 3 — Force-topology shifts

```yaml
- id: layer-b-force-topology-shifts
  routing-target: both (proposer-context + stage-3-context)
  snapshot-date: 2026-05-20
  watchpoint-ref: insight-4-substrate-attacker-becomes-substrate-architect + sub-pattern-b-mechanism-variants

  x402-agent-transaction-substrate-emergence:
    protocol-state:
      - [E] x402 = HTTP-402-payment-protocol; Coinbase + Cloudflare co-launched May 2025; uses HTTP 402 "Payment Required" status code
      - [E] settlement: USDC stablecoin on Base (primary); also Ethereum + Arbitrum + Polygon + Solana
      - [E] governance: x402 Foundation under Linux Foundation; 20+ institutional backers (Cloudflare + Stripe + AWS + Google + Visa + Circle + Solana-Foundation + Microsoft + Mastercard)

    volume:
      - [E] 2026-03: 119M transactions on Base + 35M on Solana; ~$600M annualized volume
      - [E] 2026-04-21: 69,000 active AI agents; 165M+ cumulative transactions; $50M cumulative volume
      - [E] avg-call-value: ~$0.31 (calibrated for micropayments not bulk-settlement)
      - [C] 2026-03-11 coindesk-report: ~$28K daily-volume excluding test + gamed transactions (real-commerce-adoption-narrative-ahead-of-actual-adoption)
      - [I] tension: marketing-numbers + onchain-data discrepancy = adoption-uncertain at population-scale despite frontier-integration

    integrations:
      - [E] 2026-02: Stripe integrated x402 for USDC payments on Base
      - [E] 2026-04: Coinbase Payments MCP enables anthropic Claude + google Gemini access to blockchain wallets via x402
      - [E] 2026-04-20: Base + Agentic.Market launched agent-to-agent marketplace (7 categories: reasoning + data + media + search + social + infrastructure + trading)
      - [E] World (sam-altman) AgentKit integration for human-verified AI payments
      - [E] adopters at agent-infrastructure layer: Hyperbolic (pay-per-inference GPU) + CoinGecko (onchain data access) + Cal.com (paid scheduling) + Cred-Protocol (decentralized credit-scoring) + Bankr (agent trading execution) + QuickNode

    open-questions:
      - [I] latency + settlement-finality at scale (architecture calibrated for micropayments not bulk-settlement)
      - [I] real-commerce-adoption vs gamed-volume ratio
      - [I] regulatory-treatment as adoption scales (stablecoin + crypto rails currently in regulatory-clarification phase 2025-2026)
      - [I] Google agentic-payments-protocol integration with x402 for single-tap USDC retail transactions = signal-watch-item

    substrate-attacker-becomes-substrate-architect trajectory:
      [I] x402 + agentic-commerce trajectory mirrors prior substrate-attacker-becomes-substrate-architect pattern (per layer-d insight-4):
      - direct-substitute-mode: agent-payments replace API-key + card-on-file + subscription billing for agent-to-agent transactions
      - architect-mode: agent-marketplace becomes architectural-template for new commerce-substrate (Agentic.Market 7-category structure)
      - [I] timing: pre-architect-emergence; agentic-commerce substrate-shift inflection currently active

  manufacturer-DTC-capture-trajectory:
    timeline:
      - [E] 2025-03: NovoCare Pharmacy launched (direct-Wegovy-delivery; $349-499/mo initial)
      - [E] 2025-11: Trump-administration deal with Lilly + Novo; GLP-1 price-cuts in exchange for Medicare-expansion-access
      - [E] 2026-02-05: TrumpRx.gov launched (~$350/mo most-favored-nation pricing)
      - [E] 2026-02: Novo + Lilly DTC-price-cuts cascade (NovoCare Wegovy $199-349; LillyDirect Zepbound $299-449)
      - [E] 2026-04: Lilly + Novo pricing competition intensifies; oral-GLP-1s $149/mo for lowest dose
      - [I] 2026-mid: Medicare-Part-D GLP-1 coverage starts (~10% of 66M beneficiaries eligible; $50/mo copay)
      - [I] 2026-2028: pricing trajectory to ~$245/mo per administration commitment

    market-impact:
      - [E] branded-vs-compounded price-arbitrage compressed: branded $1,000+ (2024) → branded $149-449 DTC (2026) + Medicare $50 copay; arbitrage-margin narrowed by ~70-85%
      - [E] hims-hers Sub-pattern-D-adjacent transition (compounded → branded-novo-partnership)
      - [I] compounded-GLP-1 platforms face dual-pressure: regulatory-closure (Section 2) + price-arbitrage-collapse (this Section)
      - [I] medvi Branch-B trajectory probability increased significantly Q1-Q2 2026 (regulatory + pricing compound)

  rented-infrastructure-provider-landscape:
    [E] current rented-regulated-infrastructure providers (substrate-attackers operating as substrate-architects):
    - telehealth-as-a-service: CareValidate (physician network) + OpenLoop Health (pharmacy + compliance)
    - payment-rails: Stripe (incumbent) + x402 (emerging; agent-native)
    - commerce-substrate: Shopify (incumbent) + Substack (creator-commerce vertical)
    - compute-+-AI-infrastructure: openai + anthropic + xai + google (frontier-LLM access); aws + gcp + azure (compute); Hyperbolic + Together (specialized inference)
    - regulatory-compliance-as-a-service: Plaid (banking + identity) + Stripe-Atlas (entity formation + tax)
    - data + agent-marketplace: x402 Agentic.Market + Anthropic MCP-marketplaces emerging

    [I] architecture-of-architectures-enabler instances (pattern approaching saturation per layer-d):
    - stripe-atlas: ~150K+ businesses formed; downstream Stripe-ecosystem feeder (G4)
    - substack: ~50K+ paid-creators; individual-creator + collective newsletter-business architectures (G7)
    - x402 Agentic.Market: agent-architectures using x402 as substrate (early-stage; potential 4th major instance if 2026-2027 adoption materializes)
    - candidate-watch: AWS Bedrock-AgentCore + Vercel agentic-frameworks + Google Vertex Agent Platform

  signals:
    - watch: x402 real-commerce-adoption vs gamed-volume ratio Q3-Q4 2026
    - watch: Google agentic-payments-protocol + x402 integration for retail (single-tap USDC)
    - watch: TrumpRx 2026-Q3 + Q4 patient-volume trajectory + LillyDirect + NovoCare unit-economics
    - watch: rented-infrastructure-provider acquisition-+-pricing-power-shift (CareValidate + OpenLoop position evolution)
    - watch: 4th architecture-of-architectures-enabler saturation-trigger (if 2 more instances emerge → formal pattern-12 promotion)

  cross-ref:
    affects-layer-a:
      - medvi.md (manufacturer-DTC capture compresses F2 emergence-force; vertical-diversification race trajectory)
      - stripe-atlas (architecture-of-architectures-enabler positioning)
      - substack (architecture-of-architectures-enabler positioning)
    affects-layer-d:
      - insight-6-thin-operator-ai-orchestration-rented-infrastructure (rented-infrastructure landscape current state)
      - insight-4-substrate-attacker-becomes-substrate-architect (x402 trajectory active instance)
      - sub-pattern-b-mechanism-variant-2-substrate-architect-displacement (architecture-of-architectures-enablers expanding)
    sprint-12-routing: both (force-topology context relevant for proposer-generation + stage-3-evaluation)
```

---

## Section 4 — Emerging exemplars

```yaml
- id: layer-b-emerging-exemplars
  routing-target: proposer (primary)
  snapshot-date: 2026-05-20
  watchpoint-ref: insight-6-thin-operator + pattern-6-NEW-MECHANISM-AI-orchestration-discipline

  solo-founder-unicorn-race:
    canonical-bet:
      - [E] dario-amodei (anthropic-ceo) may-2025 prediction: first billion-dollar one-person company by 2026; 70-80% odds; "seven months left on the bet" as of may 2026
      - [E] sectors-identified: proprietary-trading + developer-tools (high-margin + software-native + no-physical-ops + small-customer-support)
      - [I] medvi as nearest-data-point (1 founder + 1 employee = "almost-solo"; $401M FY2025 + $1.8B FY2026 trajectory)

    notable-instances-2025-2026:
      - [E] base44 (maor-shlomo; israel; built-alone Dec 2024; sold-to-wix $80M Jun 2025; 6-month-launch-to-acquisition; 250K-users; profitable; AI-orchestration-stack)
      - [E] medvi (matthew-gallagher + brother-elliot; los-angeles; Sep 2024 founding; $401M FY2025 / $65M net / 16.2%-margin; 2-employees; bootstrap-$20K; ~250-500K customers; see layer-a/medvi.md)
      - [E] midjourney (david-holz; <15 employees; ~$200M ARR; multi-billion valuation; image-generation substrate)
      - [I] plenty-of-fish (markus-frind; pre-AI; ~$10M+ revenue 2008; canonical pre-AI-era solo-architecture; structural-template for AI-era solo-billion)
      - [I] instagram-counterfactual (mike-krieger / anthropic-cpo statement: "with Claude Opus could have built Instagram with just himself and co-founder; no engineering team")

  context-engineering-as-discipline:
    [E] context-engineering coined by Andrej Karpathy Feb 2025 ("vibe coding"); expanded beyond coding to full-context-design-+-orchestration
    [I] discipline-features distinguishing high-performance solo-operators from baseline AI-tool-users:
      - prompt-architecture for multi-step-tasks (not single-turn-instructions)
      - tool-choice + tool-composition for specific tasks (not single-LLM-everywhere)
      - context-window-management for long-horizon-tasks
      - error-recovery-+-self-correction loops
      - evaluation-+-verification design (not trust-the-output)
    [I] mastery-distribution: small-fraction of operators reach high-performance level; broad-tool-availability ≠ broad-mastery
    [I] becoming-table-stakes-status: tool-availability commoditized 2025-2026; discipline-mastery remains differentiator

  emerging-architectural-templates:
    [I] templates beyond medvi-thin-operator-rented-regulated-infrastructure visible in current landscape:

    - AI-coding-tool-as-product: cursor + windsurf + claude-code (anthropic) + cline + github-copilot expansion (each thin-team-built; competitive landscape)
    - AI-creative-substrate: midjourney + runway + suno + udio (small-team-built; substrate-architect-trajectories)
    - AI-vertical-saas: harvey-AI (legal) + glean (enterprise search) + decagon (customer-support) — small-teams + AI-orchestration + vertical-domain-rented-infrastructure
    - agent-marketplace-operators: x402 Agentic.Market participants (early-stage; 7 categories)
    - context-engineering-consulting: emerging service-category as discipline matures

    [I] common-substrate-features matching insight-6:
      - rented-regulated-or-specialized-infrastructure (regulated-or-specialized substrate built by counterparty)
      - AI-orchestration-discipline as architectural-foundation
      - bootstrap-or-minimal-capital-model
      - vertical-or-horizontal-flow-with-large-magnitude

  failure-trajectories-watched:
    [I] notable failure-trajectories in current emerging-architecture landscape:
    - compounded-GLP-1-thin-operator mass extinction (Section 2 trajectory; medvi + ro + lifemd + henry-meds + trimi + others) — likely Q3-Q4 2026 + 2027
    - x402 + agent-commerce adoption-not-materializing (Section 3 trajectory; ~$28K daily real-volume vs $7B ecosystem-valuation = potential disconnect)
    - AI-orchestration becoming-table-stakes faster than predicted (insight-6 mechanism durability-window narrowing)

  signals:
    - watch: amodei-bet outcome by Dec 2026 (billion-dollar-one-person-company materialization or not)
    - watch: medvi vertical-diversification execution Q3-Q4 2026 (Sub-pattern-D-vs-Sub-pattern-B resolution)
    - watch: new instances entering $100M-$1B revenue range with <10 employees (population-level signal)
    - watch: failure-cascade in compounded-GLP-1 platforms (timing + magnitude indicators for substrate-shift cascade dynamics)

  cross-ref:
    affects-layer-a:
      - medvi.md (canonical exemplar; current trajectory contested)
    affects-layer-d:
      - insight-6-thin-operator-ai-orchestration-rented-infrastructure (current exemplar landscape)
      - insight-1-time-to-accumulation-distribution (year-scale exemplars + accumulation-trajectory observation)
      - pattern-6-NEW-MECHANISM-AI-orchestration-discipline (saturation-trajectory; multiple new instances)
    candidates-for-future-layer-a-entries: base44 + midjourney + cursor + harvey-AI (if architectural-decomposition warranted)
    sprint-12-routing: proposer (exemplar-context for candidate-generation; not directly evaluated by stage-3 except as comparator-cases)
```

---

## Audit

- 4 sections drafted (AI-capability + regulatory + force-topology + emerging-exemplars)
- All sections tagged with routing-target (proposer / stage-3 / both)
- All sections snapshot-dated 2026-05-20
- Evidence tags consistent (E/I/C/U) matching Layer D discipline
- Cross-references to Layer A + Layer D entries verified
- Signals section per watchpoint for next refresh-cycle awareness
- Total: ~12K tokens (target: 10-15K; under ceiling)

## Refresh log

- v1.0 (2026-05-20): initial Layer B construction post-Layer-D-commit
  - Sources: FDA federal register + onhealthcare.tech + coindesk + cryptonews + biospace + medical-news + scalable.news + greyjournal + decodethefuture + arxiv + fluxhire + github-awesome-ai-agents-2026 + buildmvpfast + theblock
  - Four watchpoints from Layer D synthesis addressed
  - Section-level routing tags for Sprint 12 selective routing
- next-refresh-trigger: per-run-start (each AlphaMo run)
- stale-flag: any section >90 days old requires re-research before reuse
